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PRELIMINARY AND SHORT REPORTS
JSONICOTJNYLHYDRAZINE (RIMIFON ®)* IN THE TREATMENT OF LUPUS
VTJLGARIS: REPORT OF A CASE
MAXIMILIAN E. OBERMAYER, M.D., J. WALTER WILsoN, M.D., AND PAUL NoRToN SMITH,
M.D.
Since it was announced that the hydrazide of iso-nicotinic acid is therapeutically effec-
tive to a promising degree in certain types of pulmonary tuberculosis it has been investi-
gated clinically in other forms of the disease (1—3) but no reports have as yet appeared
regarding its effect upon the cutaneous manifestations. However, cure or marked improve-
ment has been noted in tuberculosis of the mucous membranes of the larynx, tongue and
middle ear (2) and it is indicated that tuberculosis of the epithelial lining of the intestinal
and genito-urinary tracts also responds (2).
The drug is apparently well tolerated in the usual daily dose of 4.0 mg per kg., causing,
even when long continued, only occasional transitory episodes of constipation, difficulty
in initiating micturition, dizziness, postural hypotension and occasionally urinary albumen
and casts (1). Appetite is usually increased, weight is gained and the patients are usually
euphoric (2, 3). No toxic dermatologic manifestations have been reported.
Rapid absorption and diffusion after oral administration has been demonstrated in
tubereulous meningitis, where concentrations higher than that necessary to inhibit M.
tuberculosis (1137 RV) in vitro were observed in the cerebro-spinal fluid within 3 hours (4).
We are currently employing this drug in a few cases representing dermatologic entities
usually considered as possibly related to tuberculosis or tuberculids; a favorable trend has
been observed in all but not sufficiently marked to warrant reporting as yet.
However the response in our first case of lupus vulgaris has been so spectacular that
early publication seems desirable.
CASE REPORT
R. 0., a Mexican man 56 years of age, first noticed a painless, reddened, crusted area on
the helix of his left ear at the age of 16. During the ensuing years the involved area slowly
but steadily increased in size, completely covered the ear and spread widely over the cheek,
always exhibiting an active border and leaving atrophic scarring centrally, considerably
deforming the ear.
Treatment had consisted solely of self-selected ointments. No history indicative of pul-
monary tuberculosis could be obtained.
When first examined, the entire left ear and the cheek from the temple to the angle of
the jaw was involved with an atrophic scarring process containing occasional islands of
granuloma, and surrounded by an irregular, indurated, moderately raised, duskily ery-
thematous and mildly verrueous border. No regional adenopathy was present. The weight
was 116 pounds (52.6 kg). (Figure 1)
A positive reaction was obtained to intracutaneous tuberculin (P.P.D. No. 1). Serologic
tests for syphilis yielded negative reactions. The hemogram was normal. Roent genograms
of the chest revealed only peri-hilar calcification.
The clinical diagnosis of lupus vulgaris was confirmed by biopsy.
* From the Department of Medicine, Dermatology and Syphilology, University of
Southern California, School of Medicine.
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We are indebted to Hoffmann La-Roche, Inc., of Nutley, New Jersey for generous
supplies of Rimifon ®.
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Pie. 1. Before treatment with Rhnlfon
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TREATMENT
Isonicotinyihydrazine (Rimifon ®) was given orally, beginning with 2.0 mg per kg., and
increasing to 4.0 mg per kg. within 2 weeks, at which level it has been maintained until the
present time (total 15 weeks). No symptoms of intolerance were observed. Weekly liver
function tests however have revealed an icterus index as high as 11 units, the hemoglobin
concentration has decreased by 0.6 gram, and the patient has lost 4 pounds in weight.
At the time of this report all induration, inflammation, granulomatous nodules and ver-
rucous elevations have disappeared and only a moderate degree of scaling and slight cry-
thema persists. (Figure 2)
coNcLusIoNs
1. A case of lupus vulgaris of 40 years continuous duration involving the ear and cheek
and previously untreated scientifically, has been apparently cured within 15 weeks by the
oral administration of isonicotinylhydrazine (Rimifon ®) in a dosage of 4.0 mg per kg.
2. No toxic manifestations were encountered.
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